Australis Capital - A productive first year to say the least
Australis Capital recently reported financial results for its first year of operations. The year was characterized by a vigorous pace of deals to rapidly construct a major cannabis operator. The company now has multiple brands, access to retail spaces and supporting technology, and multiple industry partnerships and is close to completing its acquisition of Green Therapeutics (by the end of 2019), which will provide Australis with additional brands and the production it needs to launch.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.